PLGA microparticles in respirable sizes enhance an in vitro T cell response to recombinant mycobacterium tuberculosis antigen TB10.4-Ag85B

Pharmaceutical Research

Volumn 27, Issue 2, 2010, Pages 350-360

  Shi, Shuai ^a   Hickey, Anthony J ^a  

^a University of North Carolina   (United States)

Author keywords

Aerosol; Microparticles; Mycobacterium tuberculosis; Spray drying; TB10.4 Ag85B

Indexed keywords

BACTERIAL ANTIGEN; EPITOPE; INTERLEUKIN 2; NANOCARRIER; POLYGLACTIN; RECOMBINANT ANTIGEN; RECOMBINANT ANTIGEN TB10.4 AG85B; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN PRESENTATION; ANTIGEN PURIFICATION; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; EMULSION; ENCAPSULATION; ESCHERICHIA COLI; FACTORIAL DESIGN; FAST PROTEIN LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MACROPHAGE; MORPHOLOGY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SPRAY DRYING; SUSTAINED DRUG RELEASE; T LYMPHOCYTE; TUBERCULOSIS;

ADMINISTRATION, INHALATION; ANIMALS; ANTIGENS, BACTERIAL; HUMANS; LACTIC ACID; MICE; MICE, TRANSGENIC; MICROSPHERES; PARTICLE SIZE; POLYGLYCOLIC ACID; RECOMBINANT PROTEINS; T-LYMPHOCYTES;

EID: 77949274535     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-009-0028-7     Document Type: Article

References (47)

1. NE Dunlap DE Briles 1993 Immunology of tuberculosis Med Clin North Am. 77 1235 51 1:CAS:528:DyaK2cXltF2gsw%3D%3D 8231409
2. JL Flynn J Chan 2001 Immunology of tuberculosis Annu Rev Immunol. 19 93 129 10.1146/annurev.immunol.19.1.93 1:CAS:528:DC%2BD3MXivFKgtbo%3D 11244032 (Pubitemid 32368031)
3. N Brimnes 2008 BCG vaccination and WHO's global strategy for tuberculosis control 1948-1983 Soc Sci Med. 67 863 73 10.1016/j.socscimed.2008.05.016 18573583 (Pubitemid 352005831)
4. GA Colditz TF Brewer CS Berkey ME Wilson E Burdick HV Fineberg, et al. 1994 Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature Jama. 271 698 702 10.1001/jama.271.9.698 1:STN:280:DyaK2c7kt1Sqsg%3D%3D 8309034 (Pubitemid 24061706)
5. PE Fine 1995 Variation in protection by BCG: implications of and for heterologous immunity Lancet. 346 1339 45 10.1016/S0140-6736(95)92348-9 1:STN:280:DyaK28%2FmsV2nsg%3D%3D 7475776
6. JA Sterne LC Rodrigues IN Guedes 1998 Does the efficacy of BCG decline with time since vaccination? Int J Tuberc Lung Dis. 2 200 7 1:STN:280: DyaK1c7os12guw%3D%3D 9526191
7. LC Rodrigues SM Pereira SS Cunha B Genser MY Ichihara SC de Brito, et al. 2005 Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial Lancet. 366 1290 5 10.1016/S0140-6736(05)67145-0 16214599 (Pubitemid 41416584)
8. SK Mittal V Aggarwal A Rastogi N Saini 1996 Does B.C.G. vaccination prevent or postpone the occurrence of tuberculous meningitis? Indian J Pediatr. 63 659 64 10.1007/BF02730815 1:STN:280:DC%2BD3c3ovVyntw%3D%3D 10830036
9. GA Colditz CS Berkey F Mosteller TF Brewer ME Wilson E Burdick, et al. 1995 The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature Pediatrics. 96 29 35 1:STN:280:DyaK2MzhvFygsg%3D%3D 7596718
10. YA Skeiky JC Sadoff 2006 Advances in tuberculosis vaccine strategies Nat Rev Microbiol. 4 469 76 10.1038/nrmicro1419 1:CAS:528:DC%2BD28Xks1Oru7s%3D 16710326 (Pubitemid 43771866)
11. L Garcia-Contreras YL Wong P Muttil D Padilla J Sadoff J Derousse, et al. 2008 Immunization by a bacterial aerosol Proc Natl Acad Sci USA. 105 4656 60 10.1073/pnas.0800043105 1:CAS:528:DC%2BD1cXkt12qs7w%3D 18344320 (Pubitemid 351753802)
12. GA Gupta AJ Hickey 1991 Contemporary approaches in aerosolized drug delivery to the lung J Control Release 17 127 147 10.1016/0168-3659(91)90053-G 1:CAS:528:DyaK3MXmvVOjsrs%3D
13. JM Lu X Wang C Marin-Muller H Wang PH Lin Q Yao, et al. 2009 Current advances in research and clinical applications of PLGA-based nanotechnology Expert Rev Mol Diagn. 9 325 41 10.1586/erm.09.15 1:CAS:528:DC%2BD1MXlvVWkt7Y%3D 19435455
14. H Okada 1997 One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate Adv Drug Deliv Rev. 28 43 70 10.1016/S0169-409X(97)00050-1 1:CAS:528:DyaK2sXntVOjsr0%3D 10837564 (Pubitemid 27497673)
15. H Okada H Toguchi 1995 Biodegradable microspheres in drug delivery Crit Rev Ther Drug Carrier Syst. 12 1 99 1:CAS:528:DyaK2MXpsVCqs78%3D 8521523
16. H Hamishehkar J Emami AR Najafabadi K Gilani M Minaiyan H Mahdavi, et al. 2009 The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method Colloids Surf B Biointerfaces 74 340 9 10.1016/j.colsurfb.2009.08.003 1:CAS:528:DC%2BD1MXhtF2htb%2FE 19717287
17. Y Han H Tian P He X Chen X Jing 2009 Insulin nanoparticle preparation and encapsulation into poly(lactic-co-glycolic acid) microspheres by using an anhydrous system Int J Pharm. 378 159 66 10.1016/j.ijpharm.2009.05.021 1:CAS:528:DC%2BD1MXovFKqurs%3D 19465100
18. Kim BS, Oh JM, Hyun H, Kim KS, Lee SH, Kim YH, et al. Insulin-Loaded Microcapsules for in vivo delivery. Mol Pharm. 2009.
19. D Lu L Garcia-Contreras D Xu SL Kurtz J Liu M Braunstein, et al. 2007 Poly (lactide-co-glycolide) microspheres in respirable sizes enhance an in vitro T cell response to recombinant Mycobacterium tuberculosis antigen 85B Pharm Res. 24 1834 43 10.1007/s11095-007-9302-8 1:CAS:528:DC%2BD2sXhtVagt7fK 17657598 (Pubitemid 47389237)
20. J Emami H Hamishehkar AR Najafabadi K Gilani M Minaiyan H Mahdavi, et al. 2009 A novel approach to prepare insulin-loaded poly(lactic-co-glycolic acid) microcapsules and the protein stability study J Pharm Sci. 98 1712 31 10.1002/jps.21544 1:CAS:528:DC%2BD1MXlsFyqsbc%3D 18855911
21. DJ Kirby I Rosenkrands EM Agger P Andersen AG Coombes Y Perrie 2008 PLGA microspheres for the delivery of a novel subunit TB vaccine J Drug Target. 16 282 93 10.1080/10611860801900462 1:CAS:528:DC%2BD1cXlt1agtLg%3D 18446607 (Pubitemid 351622358)
22. Cal K, Sollohub K. Spray drying technique. I: hardware and process parameters. J Pharm Sci. 2009.
23. Shi S, Yu L, Sun D, Liu J, Hickey AJ. Rational design of multiple TB antigens TB10.4 and TB10.4-Ag85B as subunit vaccine candidates against mycobacterium tuberculosis. Pharm Res, doi: 10.1007/s11095-009-9995-y, 2009.
24. RL Skjot T Oettinger I Rosenkrands P Ravn I Brock S Jacobsen, et al. 2000 Comparative evaluation of low-molecular-mass proteins from Mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant T-cell antigens Infect Immun. 68 214 20 10.1128/IAI.68.1.214-220.2000 1:CAS:528:DC%2BD3cXhs1OhsQ%3D%3D 10603390
25. PS Renshaw KL Lightbody V Veverka FW Muskett G Kelly TA Frenkiel, et al. 2005 Structure and function of the complex formed by the tuberculosis virulence factors CFP-10 and ESAT-6 Embo J. 24 2491 8 10.1038/sj.emboj.7600732 1:CAS:528:DC%2BD2MXmt1ynu7s%3D 15973432 (Pubitemid 41076306)
26. RL Skjot I Brock SM Arend ME Munk M Theisen TH Ottenhoff, et al. 2002 Epitope mapping of the immunodominant antigen TB10.4 and the two homologous proteins TB10.3 and TB12.9, which constitute a subfamily of the esat-6 gene family Infect Immun. 70 5446 53 10.1128/IAI.70.10.5446-5453.2002 1:CAS:528:DC%2BD38XnsV2lsrc%3D 12228269 (Pubitemid 35050977)
27. M Daffe 2000 The mycobacterial antigens 85 complex - from structure to function and beyond Trends Microbiol. 8 438 40 10.1016/S0966-842X(00)01844-8 1:STN:280:DC%2BD3crgt1eisQ%3D%3D 11044671 (Pubitemid 30756947)
28. HG Wiker M Harboe 1992 The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis Microbiol Rev. 56 648 61 1:CAS:528: DyaK3sXhsVGitbk%3D 1480113
29. DV Havlir RS Wallis WH Boom TM Daniel K Chervenak JJ Ellner 1991 Human immune response to Mycobacterium tuberculosis antigens Infect Immun. 59 665 70 1:CAS:528:DyaK3MXhtF2rsbk%3D 1898911
30. AB Strawbridge JS Blum 2007 Autophagy in MHC class II antigen processing Curr Opin Immunol. 19 87 92 10.1016/j.coi.2006.11.009 1:CAS:528: DC%2BD2sXmtVektw%3D%3D 17129719 (Pubitemid 46073698)
31. DH Canaday A Gehring EG Leonard B Eilertson JR Schreiber CV Harding, et al. 2003 T-cell hybridomas from HLA-transgenic mice as tools for analysis of human antigen processing J Immunol Methods. 281 129 42 10.1016/j.jim.2003.07.004 1:CAS:528:DC%2BD3sXot1Ols74%3D 14580887 (Pubitemid 37324576)
32. MJ Telko AJ Hickey 2007 Critical assessment of inverse gas chromatography as means of assessing surface free energy and acid-base interaction of pharmaceutical powders J Pharm Sci. 96 2647 54 10.1002/jps.20897 1:CAS:528:DC%2BD2sXhtFKrtLbO 17518355 (Pubitemid 47597815)
33. K Hirota T Hasegawa H Hinata F Ito H Inagawa C Kochi, et al. 2007 Optimum conditions for efficient phagocytosis of rifampicin-loaded PLGA microspheres by alveolar macrophages J Control Release 119 69 76 10.1016/j.jconrel.2007.01.013 1:CAS:528:DC%2BD2sXksVejtbw%3D 17335927 (Pubitemid 46561547)
34. P O'Hara AJ Hickey 2000 Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: manufacture and characterization Pharm Res. 17 955 61 10.1023/A:1007527204887 11028941 (Pubitemid 30736598)
35. S Shi ES Ashley BD Alexander AJ Hickey 2009 Initial characterization of micafungin pulmonary delivery via two different nebulizers and multivariate data analysis of aerosol mass distribution profiles AAPS PharmSciTech. 10 129 37 10.1208/s12249-009-9185-6 19189220
36. Shi S, Hickey AJ. Multivariate data analysis as a semi-quantitative tool for interpretive evaluation of comparability or equivalence of aerodynamic particle size distribution profiles. AAPS PharmSciTech, 2009.
37. Dos Santos DF, Nicolete R, de Souza PR, Bitencourt CD, Dos Santos Junior RR, Bonato VL, et al. Characterization and in vitro activities of cell-free antigens from Histoplasma capsulatum-loaded biodegradable microspheres. Eur J Pharm Sci 2009.
38. C Wang P Muttil D Lu AA Beltran-Torres L Garcia-Contreras AJ Hickey 2009 Screening for potential adjuvants administered by the pulmonary route for tuberculosis vaccines Aaps J. 11 139 47 10.1208/s12248-009-9089-0 1:CAS:528:DC%2BD1MXhtVWqsr7O 19277872
39. AB Nastasovic AE Onjia 2008 Determination of glass temperature of polymers by inverse gas chromatography J Chromatogr A. 1195 1 15 10.1016/j.chroma.2008.05.009 1:CAS:528:DC%2BD1cXmvFSisb8%3D 18501369
40. SD Allison 2008 Analysis of initial burst in PLGA microparticles Expert Opin Drug Deliv. 5 615 28 10.1517/17425247.5.6.615 1:CAS:528: DC%2BD1cXmslOrtLc%3D 18532918 (Pubitemid 351998252)
41. R Surana L Randall A Pyne NM Vemuri R Suryanarayanan 2003 Determination of glass transition temperature and in situ study of the plasticizing effect of water by inverse gas chromatography Pharm Res. 20 1647 54 10.1023/A: 1026199604374 1:CAS:528:DC%2BD3sXotFCls7g%3D 14620521 (Pubitemid 37268282)
42. BG Jones PA Dickinson M Gumbleton IW Kellaway 2002 Lung surfactant phospholipids inhibit the uptake of respirable microspheres by the alveolar macrophage NR8383 J Pharm Pharmacol. 54 1065 72 10.1211/002235702320266217 1:CAS:528:DC%2BD38XmsF2nsb8%3D 12195820 (Pubitemid 34904835)
43. C Evora I Soriano RA Rogers KN Shakesheff J Hanes R Langer 1998 Relating the phagocytosis of microparticles by alveolar macrophages to surface chemistry: the effect of 1, 2-dipalmitoylphosphatidylcholine J Control Release 51 143 52 10.1016/S0168-3659(97)00149-1 1:CAS:528:DyaK1cXot12muw%3D%3D 9685911 (Pubitemid 28252865)
44. BG Jones PA Dickinson M Gumbleton IW Kellaway 2002 The inhibition of phagocytosis of respirable microspheres by alveolar and peritoneal macrophages Int J Pharm. 236 65 79 10.1016/S0378-5173(02)00016-9 1:CAS:528: DC%2BD38Xhslyms78%3D 11891071 (Pubitemid 34219374)
45. K Sugiyama S Mitsuno K Shiraishi 1996 Adsorption of protein on the surface of thermosensitive poly(methyl methacrylate) microspheres modified with the N-(2-hydroxypropyl)methacrylamide and 2-(methacryloyloxy)ethyl phosphorylcholine moieties J Polymer Sci Part A Polymer Chem 35 3349 3357 10.1002/(SICI)1099-0518(19971130)35:16<3349::AID-POLA2>3.0.CO;2-N
46. MC Kerr RD Teasdale 2009 Defining macropinocytosis Traffic. 10 364 71 10.1111/j.1600-0854.2009.00878.x 1:CAS:528:DC%2BD1MXnt1Cmu70%3D 19192253
47. AJ Sant FA Chaves SA Jenks KA Richards P Menges JM Weaver, et al. 2005 The relationship between immunodominance, DM editing, and the kinetic stability of MHC class II:peptide complexes Immunol Rev. 207 261 78 10.1111/j.0105-2896. 2005.00307.x 1:CAS:528:DC%2BD2MXhtFOqtL%2FL 16181342 (Pubitemid 41415023)